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To understand how the interaction between an intra-
cellular bacterium and the host immune system
contributes to outcome at the site of infection, we
studied leprosy, a disease that forms a clinical spec-
trum, in which progressive infection by the intracel-
lular bacterium Mycobacterium leprae is character-
ized by the production of type I IFNs and antibody
production. Dual RNA-seq on patient lesions iden-
tifies two independent molecular measures of
M. leprae, each of which correlates with distinct as-
pects of the host immune response. The fraction of
bacterial transcripts, reflecting bacterial burden, cor-
relates with a host type I IFN gene signature, known
to inhibit antimicrobial responses. Second, the bac-
terial mRNA:rRNA ratio, reflecting bacterial viability,
links bacterial heat shock proteins with the BAFF-
BCMA host antibody response pathway. Our find-
ings provide a platform for the interrogation of host
and pathogen transcriptomes at the site of infection,
allowing insight into mechanisms of inflammation in
human disease.
INTRODUCTION
The interactions between the host immune response and an
invading pathogen dictate the pathogenesis of an infectious dis-
ease. The spectrum of such interactions can be investigated in
leprosy, caused by the intracellular bacterium Mycobacterium
leprae, in which the clinical manifestations correlate with the
host immune response to the pathogen (Ridley and Jopling,3574 Cell Reports 26, 3574–3585, March 26, 2019 ª 2019 The Autho
This is an open access article under the CC BY-NC-ND license (http://1966). In the lesions of the self-limiting tuberculoid form (T-lep),
bacilli are rare and the immune response is characterized by a
CD4+ T cell infiltrate (Modlin et al., 1982) and an interferon g
(IFN-g) transcriptional signature, resulting in an effective antimi-
crobial responses in macrophages (Fabri et al., 2011; Montoya
et al., 2009; Yamamura et al., 1991). By contrast, the lesions of
the disseminated lepromatous form (L-lep) are characterized
by abundant bacilli, B cells, or plasma cells (Iyer et al., 2007;
Ochoa et al., 2010), and the expression of a type I IFN gene pro-
gram that suppresses macrophage antimicrobial activity (Teles
et al., 2013). Some patients undergo a reversal reaction (RR)
that manifests clinically as an upgrade from the L-lep to the
T-lep form of the disease, associated with a change from a
type I to type II IFN response.
Although M. leprae was the first human pathogen identified
under the microscope, it has not been possible to grow this bac-
terium in vitro nor to develop a genetic system to study specific
genes. Furthermore, research has been limited by the absence
of animal models that mimic the clinical and immunologic spec-
trum of human disease (Kirchheimer and Storrs, 1971; Lahiri
et al., 2005; Madigan et al., 2017a;Madigan et al., 2017b). There-
fore, the study of human skin lesions from leprosy patients pro-
vides an opportunity to investigate theM. leprae determinants of
the host immune response at the site of infection.
The advent of a dual RNA sequencing (RNA-seq) approach
has recently been applied to simultaneously sequence the tran-
scriptomes of both the host and pathogen organisms in vitro,
with the subsequent isolation of each transcriptome in silico
through alignment of the respective genomes of the organisms
(Damron et al., 2016; Niemiec et al., 2017; Nuss et al., 2017;
Tha¨nert et al., 2017; Wesolowska-Andersen et al., 2017; Wester-
mann et al., 2016; Zimmermann et al., 2017). The main challenge
to this approach had been the size difference between bacterial
and mammalian transcriptomes, which can lead to poorrs.
creativecommons.org/licenses/by-nc-nd/4.0/).
coverage of bacterial pathogens. This challenge has been ad-
dressed by molecular enrichment of bacterial RNA or by investi-
gating cell cultures and animal models in which the multiplicity of
infection is high (Damron et al., 2016; Niemiec et al., 2017; Nuss
et al., 2017; Tha¨nert et al., 2017; Wesolowska-Andersen et al.,
2017; Westermann et al., 2016; Zimmermann et al., 2017). How-
ever, studies where dual RNA-seq has been employed to
analyze lesions of a human disease are few, with one viral (We-
solowska-Andersen et al., 2017) and two microbiome dual
RNA-seq studies (Franzosa et al., 2014; Pe´rez-Losada et al.,
2015), but none of an infectious bacterial disease. We hypothe-
sized that the high bacterial burden in L-lep lesions would pro-
vide an ideal opportunity to employ a dual-RNA-seq approach
to investigate the host-pathogen interaction at the site of human
infectious disease.
RESULTS
In Situ Dual RNA-Seq of Host-Pathogen Transcriptomes
Identifies a Link between Pathogen Abundance and
Type I Interferon Signaling
To investigate the host-pathogen interaction at the site of myco-
bacterial infection, RNA-seq was performed on the total RNA
from 24 leprosy skin biopsy specimens (9 L-lep, 6 T-lep, and 9
RR) (Figure 1A). Microbeads with consensus sequences to hu-
man and bacterial ribosomal RNA (rRNA) were utilized for deple-
tion. The enriched mRNA was then converted into sequencing li-
braries by random hexamer priming, sequenced by standard
Illumina protocol, and mapped to both the human and
M. leprae genomes (see Methods Details). Hierarchical clus-
tering of both human and M. leprae transcriptomes revealed a
distinct gene expression profile in L-lep lesions compared to
T-lep and RR lesions (Figure 1B). The co-clustering of T-lep
and RR samples (which was also seen with human gene clus-
tering alone) is consistent with their similar histologic features,
as observed previously in microarray studies (Bleharski et al.,
2003; Teles et al., 2013).
With an average of 50 million reads mapping to exons,
M. leprae reads were abundantly detected in the L-lep lesions
(0.53–3.2 million exonic reads) (Table S1), consistent with the
histologic detection of bacilli in the different disease states (Rid-
ley and Jopling, 1966). The M. leprae transcriptome had an
exonic coverage (number of reads mapping to exons multiplied
by the read length, then divided by the sum of length of all exons)
of 22 ± 5.9 SEM times the total length of all exons in the bacterial
genome. Furthermore, 95% ± 0.73% SEM of M. leprae genes
had at least five average exonic reads across L-lep samples.
By contrast, the RR or T-lep lesions had fewer than 1,100 reads
mapping to M. leprae, except for three RR lesions that had
36,971, 34,213, and 9,109 reads detected. Because this repre-
sents less than 13 coverage of the transcriptome, they were
omitted from analysis. Furthermore, the fraction of the transcript
abundance (which accounts for gene length, see Methods De-
tails) mapping to M. leprae relative to abundance of transcripts
mapping to either human or M. leprae was variable across
L-lep lesions and ranged from 0.06 to 0.38 (Figure 1C; Table
S1).We next askedwhether the variation inM. leprae abundance
in the L-lep patients was linked to host immunologic features ofthe disease, through use of a gene-signature-based analysis
measuring the IFN-activation or cell type profile, which was
used to deconvolute the cellular composition of each lesion (Lo-
pez et al., 2017). We found a significant correlation of the
M. leprae abundance with an IFN-b-activation gene expression
signature (r = 0.92, p = 4.4 3 104) but not an IFN-g signature
(Figure 1D). By contrast, M. leprae abundance was not signifi-
cantly correlated with a macrophage gene expression signature
(Figure S1A), suggesting that the type I IFN response is related to
the bacterial load independently of macrophage numbers.
Finally, we also observed that the M. leprae abundance was
inversely correlated with the CD4+ T cell signature (r = 0.87,
p = 1.13 103) but did not correlate with a plasma cell signature.
Composition of the M. leprae Transcriptome
Wenext investigatedwhethermore specificproperties of thebac-
terial transcriptomemight be associatedwith immune signatures.
Examining only the lepromatous lesions in which significant
M. leprae reads were detected, structural noncoding RNAs,
including transfer messenger RNA, ribonuclease P, and 23S
rRNA, accounts for a majority of theM. leprae transcriptome (5S
and 16 s rRNA omitted) (Table S2). Abundant mRNAs included
virulence proteins that compose the ESX1 secretion system
(esxA and esxB), the ESX1-associated proteins (the apparently
operonic transcripts, espA, espC, espD MLBr00411, and PE3),
and stress protein transcripts (cspA, hsp18, groEL2, and groES),
aswell as themaster transcriptional regulatorwhiB1. Interestingly,
many of the most abundant M. leprae RNAs were encoded by
pseudogenes (TableS2), even thoughpseudogenesarenot trans-
lated into full proteins due to nonsense mutations.
Although we depleted bacterial rRNA using affinity beads, we
observed that certain regions of 23S rRNA were retained at high
coverage, presumably because the rRNA was fragmented and
certain regions were not effectively captured by the beads (Fig-
ure S2A). Sequencing a separate set of two samples sequentially
before and after rRNA depletion showed one 261-bp region in
particular that was consistently retained, while the transfer
messenger RNA (tmRNA) locus was unaffected (Figure S2B).
We postulated that we could use this retained rRNA fragment
as a surrogate for total 23S abundance. To confirm that the rela-
tive expression of this region matched 23S expression before
rRNA depletion, cDNA, which was acquired from the nine L-lep
lesions before depletion, was analyzed by qPCR. There was a
high correlation (r = 0.71, p = 0.032) between the abundance of
RNA-seq 23S and that of the 261-bp region (Figure S2C). As a
control, M. leprae esxA, an mRNA presumed to be unaffected
by rRNA depletion, also showed significant correlation (r =
0.71, p = 0.014) before and after depletion.
M. lepraemRNA:rRNA Ratio as a Bacterial Metric Linked
to a Plasma Cell Response
The viability of M. leprae cannot be assessed using the colony
forming unit assay, as the bacterium cannot be grown in culture.
Instead, M. leprae viability can be estimated from the ratio of
rRNA transcripts to genomic DNA, an approach that leverages
the difference in stability between rRNA and genomic DNA
(gDNA) (Kralik et al., 2010; Liu et al., 2012; Martinez et al.,
2009). Here we sought to extend this logic and estimate bacterialCell Reports 26, 3574–3585, March 26, 2019 3575
Figure 1. In Situ Dual RNA Sequencing of Host-Pathogen Transcriptomes
(A) Experimental design for dual RNA-seq RNA extraction, library preparation, and sequence processing.
(B) Unsupervised clustering analysis of bothM. leprae and human gene expression across leprosy skin lesions (coefficient of variation, >1.0). Heatmap represents
expression of genes (rows) and patients (columns) in which red indicates a higher and green a lower expression Z score per gene across patients (n = 24).
(C) Ratio of the sum of all M. leprae gene abundances over the total sum of human or M. leprae gene abundance across L-lep patient lesions.
(D) Correlation plots ofM. leprae abundance (log2 scale) against indicated Signature Visualization Tool (SaVanT) signature values (Z score) for IFN-b, IFN-g, CD4+
T cells, or plasma cells per L-lep patient. p value by Student’s t test (n = 9).
See also Table S1 and Figures S1 and S4.
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Figure 2. Measure ofM. lepraemRNA:rRNA
Ratio
(A) M. leprae derived from the footpad of nu/nu
mice were isolated and cultured in vitro under
starvation conditions for 0 h, 48 h, or 96 h before
RNA extraction and RNA sequencing. Data are
shown as mean transcriptional activity ± SEM per
time point (n = 2). *p < 0.05 by Student’s t test.
(B) Ratio of the log2(x + 1)-transformed sum of all
M. leprae mRNA genes divided by 23S RNA
abundance per L-lep lesion.
(C) Plot of RNA abundance versus mRNA:rRNA
M. leprae measures per L-lep patient.
(D) Scatterplots ofM. leprae transcriptional activity
versus indicated SaVanT signature score per L-lep
patient. p value by Student’s t test (n = 9).
See also Table S2 and Figures S2, S3, and S4.viability based on measurements of the RNA only, exploiting the
difference in mRNA and rRNA stabilities. For example, in vitro
mycobacterial mRNA has an average half-life of 9.5 minutes,
whereas rRNA has an average half-life over 24 h (Cangelosi
and Brabant, 1997; Rustad et al., 2013). To validate that the
mRNA:23S ratio correlates with the M. leprae viability, we
measured the ratio of mRNA:rRNA inM. leprae gene expression
data from various conditions in which the physiologic state of
M. leprae is known to vary. M. leprae bacteria grown in the
mouse footpad of immunocompromised (athymic nu/nu) mice
were purified and placed into axenic culture for 0–96 h. We
calculated the M. leprae mRNA:rRNA ratio by dividing the sum
of the transcript abundance of all bacterial mRNA genes by the
transcription abundance of 23S (based on the 1343455–
1343551 region). We find that in these conditions, the
M. leprae mRNA:rRNA ratio significantly decreased with time
(n = 2, p = 0.005 at 48 h, p = 0.006 at 96 h) (Figure 2A), indicating
that the ratio tracks the viability of the bacteria. A second series
of analyses were performed using data from conditions in which
M. tuberculosis H37Rv was depleted of all nutrients and grown
only in PBS orM. tuberculosis H37Rv during log or transcription-
ally quiescent stationary phase (Arnvig et al., 2011; Cortes et al.,
2013). The M. tuberculosis mRNA:rRNA ratio was significantly
lower in bacteria after nutrient depletion (p = 0.027) or in bacteria
harvested in stationary phase than that in exponential phase (p =
0.002), further supporting our interpretation of this ratio (Figures
S3A and S3B).Cell RepTo validate the two M. leprae (MLEP)
RNA-seq bacterial measures, MLEP
abundance, and the MLEP mRNA:rRNA
ratio, we sequenced a separate set of
seven lepromatous leprosy patient sam-
ples in which the current standard mea-
sures of bacterial burden and bacterial
viability had been measured. Further-
more, to avoid 23S ribosomal depletion
issues, these samples were not depleted
for bacterial rRNA and the 23S transcrip-
tional abundance was calculated both by
the 1343455–1343551 region or the fulllength. The MLEP abundance, calculated by the 23S region or
23S full length, significantly correlated (r = 0.83, p = 0.02; r =
0.79, p = 0.02, respectively) with the current clinical standard
to assess leprosy bacterial burden, the skin bacillary index (Rid-
ley, 1957) (Figure S4A). Similarly, the MLEP mRNA:rRNA ratio,
measuring either the 23S region or 23S full length correlated
significantly (r = 0.88, p = 0.004; r = 0.78, p = 0.02, respectively)
with the M. leprae 16S rRNA to the MELP-specific repetitive
element (RLEP) genomic DNA measured by quantitative real-
time PCR (Kralik et al., 2010; Liu et al., 2012; Martinez et al.,
2009) (Figure S4B).
Having established that the ratio of mRNA to rRNA provides a
distinct metric of theM. leprae physiologic state, we next asked if
its variation across L-lep lesions correlated with host gene
expression signatures that are characteristic of L-lep patients.
This value was found to vary across L-lep lesions (Figure 2B;
Table S1), and was largely independent ofM. leprae abundance
(Figure 2C; r = 0.11, p = 0.79). We found that the M. leprae
mRNA:rRNA ratio was significantly negatively correlated with
the plasma cell signature (r = 0.84, p = 0.005) but not the
IFN-b, IFN-g and CD4+ T cell signatures in L-lep lesions
(Figure 2D).
Identification of an M. leprae Gene Module Associated
with Host Antibody Production in L-Lep Lesions
To identify theM. leprae gene modules associated with the vari-
ation inM. lepraemRNA:rRNA ratio, a weighted-gene correlationorts 26, 3574–3585, March 26, 2019 3577
Figure 3. Module Analysis of M. leprae Transcriptome
(A) Unsupervised weighted gene-correlation analysis (WGCNA) of the M. leprae gene expression across the nine L-lep patients. Heatmap represents the cor-
relation of the module eigengene (rows) versus bacterial measure (columns) in which red indicates a positive and blue a negative Pearson correlation across
patient samples. Number of genes per module indicated beside module color. Black outlines indicate highest and lowest correlation values.
(B) Correlation plot of the MLEPpurple module gene, esxA, and the M. leprae abundance per L-lep patient (n = 9).
(C) Heatmap of MLEPblue or MLEPcyan module protein-coding genes (pseudogenes excluded) across L-lep patients in order of M. leprae mRNA:rRNA (top).
High or low relative expression indicated by red or blue, respectively.
(legend continued on next page)
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analysis (WGCNA) was performed on the bacterial transcriptome
(Figure 3A) (Langfelder and Horvath, 2008; Montoya et al., 2014).
WGCNA is an unsupervised clustering method that uses correla-
tions across samples to group genes into modules, similar to
traditional clustering analysis, but also accounts for the network
neighborhood of a given set of genes, thus lending more weight
to gene networks with more reliable correlations. Each resultant
module is given an arbitrary color name and represents a set of
highly interconnected genes that change expression coordi-
nately across samples. To account for the varying abundance
of bacilli across patient lesions, the relative percentage of total
bacterial mRNA was input for each M. leprae gene. We found
that among the 14 modules that we identified, the M. leprae
RNA abundance measure correlated most highly with the
average transcriptional abundance (module eigengene) of the
MLEPpurple module, although this did not reach significance
(r = 0.5, p = 0.2). The MLEPpurple module contained two major
components of the genes of the ESX-1 secretion system esxA
and esxB, which are required for type I IFN induction in macro-
phages by mycobacterial infection (Stanley et al., 2007). The
relative expression of esxA was significantly correlated with the
M. leprae RNA abundance (r = 0.71, p = 0.03; Figure 3B), and
correlated with type I IFN gene signature but did not reach signif-
icance (r = 0.66, p = 0.053; Figure S1B). Meanwhile, theM. leprae
mRNA:rRNA ratio positively correlates with theMLEPcyanmod-
ule eigengene, (r = 0.84, p = 0.005), and the MLEPblue module
eigengene composed of 257 genes inversely correlates with
the M. leprae mRNA:rRNA ratio (r = 0.75, p = 0.02) (Figures
3A and 3C; Table S3).
The functional categories associated with the significantly
correlatedM. leprae genemoduleswere investigated using anno-
tations from the Mycobrowser (Kapopoulou et al., 2011). The
MLEPcyan and MLEPblue modules were significantly enriched
in the ‘‘virulence, detoxification, adaptation’’ functional category
defined by Mycobrowser, but we noted there were numerous
heat shock proteins (HSPs); hence, we designate them as ‘‘viru-
lence and HSPs’’ (Figure 3D). TheMLEPbluemodule in particular
was enriched in genes encoding HSPs, whereasMLEPcyan con-
tained none. Furthermore, an additional enrichment in ‘‘interme-
diary metabolism’’ was identified for the blue module. The corre-
lation of individual MLEPblue virulence genes with M. leprae
mRNA:rRNA ratio correlated with module membership, a mea-
sureof thegenesmosthighlyconnected to themodule (Figure3E).
Interactions between the M. leprae and Host
Transcriptomes
To further understand the interaction between the bacterial and
host transcriptomes in leprosy, the WGCNA module eigengenes
derived from the M. leprae transcriptome and the metrics for
bacterial abundance and the mRNA:rRNA ratio were correlated
with the WGCNA modules derived from the human transcrip-
tome within the same lesions. Of the 36 human modules gener-(D) Functional category enrichment of genes within theMLEPblue orMLEPcyanm
enrichment p value per functional category. *p% 0.05.
(E) Plot of theWGCNAmodulemembership and the correlation to theM. lepraemR
by Student’s t test (n = 9).
See also Figure S1 and Table S3.ated, nine were highly correlated (p < 0.001) with the M. leprae
mRNA:rRNA ratio, abundance, or module eigengenes of the
MLEPblue or MLEPcyan modules (Figure 4A). The most signifi-
cant correlation was between the HUMANgreenyellow and the
MLEPblue module eigengenes (r = 0.78, p = 7 3 106). Gene
set enrichment analysis (GSEA) (Subramanian et al., 2007) of
the HUMANgreenyellow module genes identified ‘‘humoral im-
mune response’’ as the top term, accounting for 27 of the 575
genes in the module. Overall, immunoglobulin genes accounted
for 215 (37%) of the genes in module, including all of the immu-
noglobulin heavy chain constant genes (IGH), which determine
antibody isotype (Figure 4B; Table S3). IGH transcripts were
seven-fold more abundant in L-lep versus T-lep lesions, in part
due to the dominance of IGHM transcripts. Of the class-
switched isotypes, the total of the IGHG subtypes predominated
in L-lep lesions followed in expression by IGHA (Figure 4B).
Further investigation by ingenuity pathways analysis (IPA)
of HUMANgreenyellow indicated the canonical pathway most
significantly enriched to be ‘‘Communication between Innate
and Adaptive Immune Cells’’ (hypergeometric enrichment
p value, 1.713 1016), identifying a pathway for immunoglobulin
production. This pathway contains the ligands BAFF (B-cell-acti-
vating factor, also known as [aka] TNFSF13B) and APRIL (a
proliferation-inducing ligand, aka TNFSF13), which activates
the B cell receptor BCMA (B cell maturation antigen, aka
TNFRSF17), leading to production of immunoglobulin G (IgG)
and IgA, all of which were differentially expressed in L-lep
versus T-lep lesions (Figure 4C). In addition to BCMA, the
HUMANgreenyellow module genes IGHA1, IGHA2, and IGHG2
had significant inverse correlations with the M. leprae
mRNA:rRNA ratio (r = 0.84, p = 0.005; r = 0.79, p = 0.011;
r = 0.76, p = 0.017, respectively; Figure 4D). BCMA inversely
correlated with the M. leprae mRNA:rRNA ratio (r = 0.77, p =
0.008) but positively correlated with the plasma cell signature
(r = 0.96, p = 4 3 105) (Figures 4D, 4E, and S5A).
Although BAFF and APRIL were not present in the
HUMANgreenyellow, they were significantly higher in L-lep
versus T-lep or RR patients (1.7 fold-change, p adjusted
[padj] = 0.004, 1.6 fold-change, padj = 0.007, respectively).
Although APRIL was expressed in L-lep lesions, it did not corre-
late with either M. leprae mRNA:rRNA ratio or abundance.
By contrast, BAFF expression significantly correlated with the
M. leprae abundance (r = 0.81, p = 0.008) but not the
mRNA:rRNA ratio, the plasma cell signature, nor IGH expression
(Figure 4D). BAFF expression did correlate with the type I IFN
activation signature score (r = 0.71, p = 0.032) across L-lep pa-
tients (Figures 4D and 4E; Figure S5B). M. leprae abundance is
likely linked to BAFF expression through type I IFN production,
because in vitro M. leprae infection of monocyte-derived macro-
phages induces type I IFN (Teles et al., 2013) and BAFF (Fig-
ure S5C). Lastly, type I IFN stimulation induces BAFF in unin-
fected macrophages (Figure S5C).odules. Heatmap color indicates the negative logarithm of the hypergeometric
NA:rRNAper gene from theMLEPblue virulence and heat shock genes. p value
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Figure 4. Interactions between Host and Pathogen Transcriptomes
(A) WGCNA of the human gene expression across all leprosy patients (n = 24). Heatmap represents the correlation of the host module eigengene (rows) versus
bacterial measure (columns) in which red indicates a positive and blue a negative Pearson correlation across only the nine LL patient samples. Only modules with
a significant correlation (p < 0.001) in at least one bacterial measure or module eigengene are shown. Black outline indicates most significant positive correlation.
(legend continued on next page)
3580 Cell Reports 26, 3574–3585, March 26, 2019
Because BCMA expression appears to be linked to antibody
expression, we investigated how the MLEPblue ‘‘virulence and
HSP’’ genes were individually connected with BCMA expres-
sion. Six M. leprae genes (aac, ML0493, clpB, groEL1, groEL2,
and hspR) significantly correlated with the expression of
BCMA, the plasma cell signature, IGHA1, IGHA2, IGHG2, and
the total amount of IGH (Figures 5A). GroEL1 and groEL2 also
particularly demonstrated a strong correlation with the class-
switched IGHA1 and IGHG2 antibody production (Figures 5A).
To further understand the relevance of BAFF and BCMA to
antibody responses in L-lep patients, we investigated the
expression of key immune response genes and signatures
across the leprosy disease spectrum. As previously stated,
BAFF, BCMA, IGH, as well as the individual immunoglobulin iso-
forms were more strongly expressed in L-lep versus T-lep and
RR lesions (Figure 5B). The plasma cell signature linked to
BCMA and the type I IFN signature linked to BAFF were also
greatest in L-lep lesions. Although BAFF and BCMA expression
were highest in L-lep lesions, only the level of BCMA expression
across all leprosy patients was tightly correlated with the total
antibody expression (r = 0.94, p < 1 3 106; Figures 5B and
5C). Together, these data indicate that BCMA expression is cen-
tral to immunoglobulin production at the site of disease in leprosy
and is linked to the decreasedM. lepraemRNA:rRNA ratio and a
stress response gene module.
DISCUSSION
The locus of the battle between pathogens and host is primarily
in tissue lesions, about which remarkably little is known for many
pathogens. To define the molecular determinants of the host-
pathogen interaction at the site of an easily accessiblemycobac-
terial infection, we performed dual RNA-seq on leprosy lesions,
simultaneously measuring both the human and M. leprae tran-
scriptomes. The clinical spectrum of leprosy is defined by the
number of skin lesions and microscopic quantification of bacilli,
which grossly correlate with the host immunologic responses
(Ridley and Jopling, 1966). Because M. leprae cannot be grown
in vitro, it is not readily possible to determine the viability of the
bacilli in lesions. Here, we define two independent molecular
measures ofM. leprae, each of which correlates with distinct as-
pects of the host immune response (Figure 5D). The first is the
bacterial burden, represented by the fraction of bacterial tran-
scripts, which correlates with a host type I IFN gene signature.
However, the bacterial burden did not correlate with the host
plasma cell gene signature. We overcome this limitation byNumber of genes per module indicated beside module color and top gene ontol
q-value for enrichment per module.
(B) Mean abundance of IGH immunoglobulin constant regions per leprosy clinica
RR], n = 15).
(C) Ingenuity pathways canonical pathway communication between innate and ad
shown.HUMANgreenyellowmodule genes shaded green and genes significantly
in red; Bonferoni-adjusted p value by Wald test).
(D) Correlation heatmap of BAFF and APRIL ligands and BCMA receptor express
signature score, and individual immunoglobulin IGH constant region genes acr
respectively.
(E) Correlation plots of M. leprae bacterial measures across L-lep skin lesions ve
See also Figures S4 and S5 and Table S3.considering a second property of bacilli, namely, the ratio of bac-
terial mRNA to rRNA, which was independent of the M. leprae
RNA abundance. This second metric, theM. lepraemRNA:rRNA
ratio, correlatedwith the bacterial viability in lesions and in in vitro
culture of mycobacteria in different conditions. We find that
the M. leprae mRNA:rRNA ratio in each individual is strongly
correlated with the abundance of plasma cells, as measured
by the plasma cell signature. Simultaneous measurement of
both the human and M. leprae transcriptomes enabled us to
identify associations between the host and pathogen, including
a link between mycobacterial ‘‘stress response’’ and ‘‘human
antibody response’’ gene networks, providing a precision med-
icine approach to identifying critical determinants of disease
pathogenesis.
The clinical spectrum of leprosy defines a subgroup of pa-
tients, L-lep, presenting with disseminated lesions containing a
high bacterial load. The current standard to assess bacterial
burden in the clinical setting of leprosy is the bacillary index
(BI), which was developed 61 years ago and determined through
enumeration of acid-fast-stained bacteria per high-powermicro-
scopic field from blood slit smears from either the earlobe or the
disease lesion (Ridley, 1957). Here, we developed a molecular
definition of bacterial burden, measuring the M. leprae RNA
abundance, finding that this metric correlated strongly with a
host type I IFN signature. Previously, we found that IFN-b secre-
tion by macrophages correlated with the multiplicity of infection
byM. leprae in vitro (Teles et al., 2013). In addition, although the
relative expression of mycobacterial esxA has been demon-
strated in experimental models to be required for mycobacte-
ria-induced type I IFN expression, we provide evidence linking
M. leprae esxA to the human type I IFN signature at the site of
infection. Although the type I IFN inducible program is a major
immune factor for control of viral infection, it has been shown
to suppress antibacterial responses, particularly to intracellular
infections (Boxx and Cheng, 2016; Teles et al., 2013).
Although humoral immune responses are robust in multibacil-
lary L-lep patients, little is known about antibody production at
the site of infection (Iyer et al., 2007; Ochoa et al., 2010). We
found that WGCNA was a powerful approach to associate bac-
teria and host gene networks, uncovering a molecular mecha-
nism that links the M. leprae mRNA:rRNA ratio to the plasma
cell response. A low bacterial mRNA:rRNA ratio correlated with
an M. leprae network, MLEPblue, which was linked to a host
gene module, HUMANgreenyellow, that was enriched for anti-
body genes and BCMA, a cell surface receptor on plasma
cells known to induce IgA and IgG class-switched antibodyogy terms for module genes listed on right with the false discovery rate (FDR)
l subtype (LL, n = 9; tuberculoid leprosy and reversal reaction leprosy [TL and
aptive immune cells. Only the section of pathway containing enriched genes is
higher in LL versus TL and RR patients (fold change,R1.5; padj% 0.05 outlined
ion versusM. leprae bacterial measures, human SaVanT plasma cell and IFN-b
oss L-lep patients. High or low Pearson correlation indicated by red or blue,
rsus BAFF or BCMA expression. p value by Student’s t test (n = 9).
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Figure 5. Bacterial Stress Proteins Are
Linked to BAFF-BCMA-Induced Antibody
Expression
(A) Correlation heatmap of MLEPblue virulence
and heat shock genes (columns) versus MLEP
mRNA:rRNA and components of the host antibody
response. Positive or negative Pearson correlation
indicated by red or blue, respectively (n = 9).
(B) Heatmap of expression of human immune
response components across the spectrum of
leprosy clinical subtypes (n = 24). Color represents
the Z score across each row with red as high and
blue as low relative expression.
(C) Correlation plot of the total IGH abundance
versus BCMA or BAFF expression across the
spectrum leprosy samples (L-lep, T-lep, and RR).
p value by Student’s t test (n = 24).
(D) Model for interaction between the pathogen
and host humoral response. Themodel shows that
bacterial abundance is correlated with induction of
IFN-b leading to BAFF expression. At the same
time, decreasedM. lepraemRNA:rRNA is linked to
the expression of M. leprae heat shock proteins,
which can trigger TLR4 activation on plasma cells
to upregulate the BAFF receptor BCMA. The
BAFF-BCMA interaction results in maturation and
survival of class-switched antibody plasma cells.production in B cells (Marsters et al., 2000). A ligand for BCMA,
BAFF, correlated withM. leprae abundance and a type I IFN pro-
gram. These data identify a mechanism connecting M. leprae
abundance and the mRNA:rRNA ratio, likely reflecting bacterial
viability, leading to the enhanced humoral response in L-lep pa-
tients. BCMA but not BAFF expression was tightly linked to the
immunoglobulin expression across the spectrum of leprosy.
Mining the correlated bacteria and human gene networks, we
identified an association between the gene expression of
M. lepraeHSPs and BCMA.We suggest thatM. leprae under im-
mune attack are stressed and transcriptionally low, cutting back
on protein synthetic functions and increasing the ratio of expres-
sion of proteostasis genes, such as HSPs (Lupoli et al., 2016).
Furthermore, some stressed bacteria are dying, releasing their
major cytoplasmic and nuclear contents. This would include
DNA (Kim et al., 2011), known to trigger Toll-like receptor 93582 Cell Reports 26, 3574–3585, March 26, 2019(TLR9) on B cells, and plasma cells, lead-
ing to upregulation of BCMA, thereby
allowing the BCMA ligand BAFF to
augment antibody production. Alterna-
tively, the increased ratio of HSPs can
be released by dying bacteria (Vargas-
Romero et al., 2016) and subsequently
released from dying macrophages or
secreted in exosomes (Giri et al., 2010).
Of these proteins, GroEL1 and/or GroEL2
and DnaK, have been shown to activate
TLR4 (Asea et al., 2002; Bulut et al.,
2005), which is also present on plasma
cells (Dorner et al., 2009). These HSPs
are also known to be major antigens forthe antibody response (Young et al., 1988). We noted that
GroEL2 expression had the strongest correlation with an IgA1
antibody response, characteristic of a mucosal immune
response, perhaps reflecting nasopharyngeal involvement in
leprosy patients (Barton, 1975).
The link of GroEL1 and/or GroEL2 expression to an antibody
response may reflect the immune system’s attempt to mount a
host defense response. In tuberculosis, antibodies have been
shown to contribute to an antimicrobial response against myco-
bacteria (Lu et al., 2016). Targeting of HSPs has long been used
for bacterial vaccine design and in particular, M. leprae GroEL2
(Lima et al., 2003; Lorenzi et al., 2010; Lowrie et al., 1999; Souza
et al., 2008; Tascon et al., 1996); and intranasally administered
M. tuberculosis DnaK (Chuang et al., 2018) has been shown to
engender protective cell-mediated and humoral immune re-
sponses to tuberculosis in mousemodels. Our data demonstrate
a correlation between the decreasedM. lepraemRNA:rRNA ratio
with bacterial HSP expression and the host humoral response,
suggesting the need for further investigation of the efficacy of
mycobacterial HSPs in prophylactic vaccines. On the other
hand, the link between M. leprae HSP gene expression and the
host antibody response may reflect pathogenesis of the infec-
tion, indicating release of bacterial products that contribute to
immunopathology. Although the expression of BAFF, BCMA,
and antibody genes varied in L-lep patients, the levels were
generally higher than in T-lep or RR patients. Excessive BAFF
signaling of B cells has been shown to increase autoantibody
production (Gross et al., 2000; Mackay et al., 1999; Zhang
et al., 2001), which are prominent in L-lep patients complicating
the differential diagnosis of systemic lupus erythematosus and
syphilis (de Larran˜aga et al., 2000; Loizou et al., 2003).
Previous studies seeking to gain insight into the battle be-
tween the host and a pathogen through dual RNA-seq have
been limited to the study of infected cells in tissue culture or in
mousemodels of infection, often using genetically modified bac-
teria or different mouse strains. It is difficult to translate this
approach to human infectious disease given that both the path-
ogen and the host cannot be genetically modified. Here, wewere
able to define host-pathogen transcriptional associations in le-
sions of a human disease. The complex cellular environment of
tissue specimens provides a bioinformatics challenge to anal-
ysis. Previous dual RNA-seq studies of in-vitro-infected cells
have been limited to only one cell type, whereas in vivo studies
in mouse models lacked analysis of the tissue cellular environ-
ment (Damron et al., 2016; Nuss et al., 2017; Pittman et al.,
2014; Tha¨nert et al., 2017). Here, we developed a computational
framework that reduces each disease lesion into a series of
scores representing the host cellular immune pathways and
pathogen abundance or physiologic state. This reduction
enabled us to correlate the spectrum of interactions between
the pathogen and host immune response, identifying human
and bacterial gene modules that are co-regulated across pa-
tients. Together, the transcriptional state and bacterial burden
that varied across patients provide separate but informativemet-
rics about the pathogenesis of mycobacterial disease that are
likely to be general for other intracellular pathogens, revealing
that the immune system responds to bacterial states and not
just their abundance. As such, this approach provides a para-
digm for investigating additional host-pathogen interactions in
human disease.STAR+METHODS
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EXPERIMENTAL MODELS AND SUBJECT DETAILS
Human subjects
Adult patients over the age of 18with leprosywere allocated into appropriate experimental groups through classification according to
the criteria of Ridley and Jopling (1966); all T-lep patients (2 females, 4male) classified as borderline tuberculoid, and all L-lep patients
(1 female, 5 male, 3 gender not reported) had lepromatous leprosy. All L-lep and T-lep skin biopsies were taken at the time of diag-
nosis before treatment, and reversal reaction biopsies (5 female, 2 male, 3 gender not reported) were upgrading from patients orig-
inally diagnosed with borderline lepromatous leprosy, therefore starting from a different part of the disease spectrum than the L-lep
group. In previous studies of the leprosy transcriptomes we have found five patient samples per patient group to provide sufficient
power to discern clinical status through hierarchical clustering (Bleharski et al., 2003; Montoya et al., 2009; Teles et al., 2013), here
more than six samples per leprosy subclassification were sequenced. For determining correlations across lepromatous leprosy pa-
tients, a sample size power analysis at 70% power (1-b) and a type I error rate of a = 0.05, revealed that at least eight subjects were
needed at a pearson correlation coefficient r = 0.80 (Sample size = (standard normal deviate for a significance + standard normal
deviate for b)/ln[(1+r)/(1-r)]). All leprosy patients were recruited with informed consent and approval from the Institutional Review
Board of University of Southern California school of Medicine or the institutional ethics committee of Oswald Cruz Foundation, as
well as the University of California, Los Angeles.
Monocyte derived macrophages experiments were derived from healthy human blood. Adult human donors were recruited with
informed consent and approval from the Institutional Review Board of the University of California at Los Angeles, gender of cells
was not reported under this protocol.e1 Cell Reports 26, 3574–3585.e1–e3, March 26, 2019
Mycobacterial strains
Mycobacterium leprae TN was grown in the footpad of nu/nu mice and harvested at log phase of growth (Lahiri et al., 2005) at the
National Hansen’s Disease Program Laboratory.Mycobacterium tuberculosis H37Rv experimental data was derived from a re-anal-
ysis of previously published studies (Arnvig et al., 2011). Nutrient deprivation experiment was performed by growingM. tuberculosis
H37Rv in Middlebrook 7H9 medium supplemented with 0.4% glycerol, 0.085% NaCl, 0.5% BSA, and 0.05% Tyloxapol. For nutrient
depletion condition, exponentially growing bacteria were washed, resuspended in PBS supplemented with 0.025% Tyloxapol, and
cultured for a further 24h. RNA was extracted and Illumina Sequencing libraries were constructed and sequenced as described
(Cortes et al., 2013). In the exponential and stationary phase M. tuberculosis comparison, H37Rv was grown in Middlebrook 7H9
supplemented with 0.2% glycerol and 10% ADC. Exponential phase cultures were harvested at OD600 0.6 to 0.8; stationary phase
cultures were harvested one week after OD600 had reached 1.0. RNA was from three independent exponential phase cultures of
M. tuberculosis and two stationary phase cultures were used to generate cDNA preparations that were then analyzed by Illumina-
based sequencing as described (Arnvig et al., 2011).
METHODS DETAILS
Dual RNA-seq of leprosy skin lesions
Frozen tissue sections of nine L-lep, nine RR, and six T-lep frozen skin lesions were cut into multiple ten micron sections and lysed in
QIAGEN RLT buffer with 0.1% b-mercaptoethanol (Invitrogen). To ensure efficient lysis of mycobacterial cell wall, lysates were ho-
mogenized with 0.1mm silica beads (MP Biomedicals, Santa Ana, CA) in the FastPrep3000 twice at a setting of 6.5 for 45 s. RNAwas
extracted via QIAGEN AllPrep Kit (QIAGEN, Hilden, Germany). rRNA was depleted with the Illumina Ribo-Zero Gold rRNA Removal
Kit (Epidemiology) before sequencing library preparation with the Illumina Truseq Stranded Total RNA Sample Preparation Kit. A sec-
ond set of eight lepromatous leprosy lesions were isolated for validation by the samemethod above, however only the human but not
bacteria rRNAwas depleted by Ribo-Zero Gold rRNA Removal Kit (Human/Mouse/Rat). Libraries were sequenced on the HiSeq2000
Sequencer (Illumina) at single-end 50 bp reads. Reads with poor quality were trimmed by Trim Galore! (http://www.bioinformatics.
babraham.ac.uk/projects/trim_galore) and high quality reads weremapped to the hg19 human genome via STAR (Dobin et al., 2013).
Unmapped reads after human genome alignment weremapped to the Br4923M. leprae genome (Assembly ASM2668v1). The sumof
exonic reads per genewere counted using HTSeq (Anders, 2010) using theGENCODEGRCh37-mapped version Release 24 (Harrow
et al., 2012). Although, M. leprae 16S rRNA, was depleted, a 96bp region (1343455-1343551) of the 23S rRNA remained abundant
(Figure S2). Presumably, the approach to deplete rRNA did not include oligonucleotides that bound to these sequences and rRNA
was fragmented. To confirm, the entire M. leprae 23S rRNA sequence and undepleted region were entered into the manufacturer
website Epicenter Matchmaker (http://www.illumina.com/products/selection-tools/rna-matchmaker-tool.html) and indicated ‘‘No
Match’’ for binding of Ribozero depletion probes, while the well-depleted 16S rRNA sequence indicated a 65%–85%match. Expres-
sion ofM. leprae 23S rRNA and esxAweremeasured by quantitative real-time PCRKAPA SYBR FAST (MilliporeSigma, St Louis, MO)
of cDNA synthesized from the same lesional RNA used in sequencing but before any ribosomal depletion. The relative quantities of
the gene tested per sample were calculated against the GAPDH mRNA using the CT formula as previously described (Teles et al.,
2013).
M. leprae axenic culture
For nutrient deprivation experiment ofMycobacterium leprae TN, bacteria were harvested frommouse footpad then cultured at 33C,
5% O2 in National Hansen’s Disease Program (NHDP) medium for 48h or 96h post-harvest. NHDP medium components per liter are
monopotassium phosphate 2.0 g, disodium phosphate 1.5 g, monosodium glutamate 0.5 g, sodium citrate 0.1 g, ammonium sulfate
0.5 g, pyridoxine 0.001 g, ferric ammonium citrate 0.04 g, magnesium sulfate 0.05 g, zinc sulfate 0.001 g, copper sulfate 0.001 mg,
biotin 0.5 mg, calcium chloride 0.5 mg, bovine albumin (Fraction V) 0.5 g, dextrose 7.5 g, casitone 1.0 g. Total RNA ofM. leprae was
extracted and rRNA depleted with Illumina Ribo-Zero Gold rRNA Removal Kit (Bacteria). The Solid 5500 system was used for
sequencing and quality control, alignment was performed by Maverix Biomics (San Mateo, CA). Gene counts (including 23S regional
calculation) and mRNA:rRNA ratio were calculated as described for lesional RNaseq analysis.
M. leprae infection of macrophages in vitro
Peripheral blood mononuclear cells were isolated from healthy human blood through Ficoll gradient separation. Monocytes were
then purified by CD14+ microbead enrichment (Miltenyi Biotec Bergisch Gladbach, Germany) according to manufacturer protocol.
Monocytes were differentiated into macrophages for 5 days in M-CSF 50ug/ml in 10% fetal calf serum (FCS) in GIBCO RPMI 1640
medium 37C (ThermoFisher Scientific, Waltham, MA) (Realegeno et al., 2016). Macrophages were infected at a multiplicity of infec-
tion of ten bacteria per cell from liveM. leprae, in antibiotic-free RPMI medium with 10% FCS at 33C. At indicated time points, RNA
was extracted by QIAGEN AllPrep Kit (QIAGEN, Hilden, Germany). rRNA was depleted and Illumina stranded libraries prepared,
sequenced, and raw data analyzed in same method as leprosy skin lesions.Cell Reports 26, 3574–3585.e1–e3, March 26, 2019 e2
QUANTIFICATION AND STATISTICAL ANALYSIS
RNA-seq data analysis
Filtered read counts (containing genes withR 5 reads in at least one patient group) from bacterial and human transcriptomes were
normalized via DESeq2 (Love et al., 2014) using default parameters, except for basing scaling factors on only human genes. DESeq2
normalized gene counts and rlog-transformed counts were output and used for subsequent data analysis. Unsupervised hierarchical
clustering was performed on rlog gene counts filtered for adequate expression ofR 5 rlog of gene in at least 20% of samples and
filtered for variance by having a CVR 0.2 rlog. Transcript abundance per gene was calculated by dividing the number of normalized
read counts per gene by the gene length (exons only).M. leprae RNA abundance was calculated by taking the sum of the transcript
abundance of all bacterial genes was divided by the total abundance of bacterial or human genes per sample. The M. leprae
mRNA:rRNA ratio was calculated by dividing of the sum of the transcript abundance of all bacterial mRNA genes by the transcription
abundance of 23S (based on the 1343455-1343551 region). A log transformation (log2(x+1)) of theM. leprae mRNA:rRNA ratio was
used for all analyses.
SaVanT cell signature calculation
Cell type signatures were calculated using the web-based Signature Visualization Tool (SaVanT; http://newpathways.mcdb.ucla.
edu/savant) (Lopez et al., 2017). In brief, SaVanT calculates a cell type score based on averaging a set of pre-calculated signature
genes for each cell type which is proportional to the cell abundance within the sample. Human data from skin lesions (rlog-trans-
formed gene counts) were input into SaVanT with the setting to use the top 50 genes per signature for score calculation. Since
the output scores are in arbitrary expression units, the z-score was calculated per sample relative to all samples to depict the
same scale for all signatures.
Weighted gene correlation analysis (WGCNA) and gene enrichment analysis
Module analysis of bacterial or human correlation networks was performed using Weighted Gene Correlation Analysis (WGCNA)
(Langfelder and Horvath, 2008). The fraction abundance of mRNA for M. leprae transcriptome was calculated by dividing the tran-
scriptional abundance of each gene (DESeq2 normal counts/gene length) by the sum of all abundances of mRNA genes. Input for the
M. leprae WGCNA was the mRNA fractional abundance with log-transformation (log2(x + 1)) and human WGCNA was rlog-trans-
formed output from DESeq2 normalization. A signed gene correlation network was constructed using the ‘‘blockwiseModules()’’
function with a soft thresholding power of 12 for human and 16 forM. leprae and using a minimum module size of 50 genes, merged
cut threshold of 0.3, and deepSplit of 0 for both analyses. Themodule eigengene, which represents a linear combination of genes that
capture a large fraction of variance in each module, was calculated for each sample and correlated to M. leprae abundance or
mRNA:rRNA ratio per sample.
Bacterial module gene enrichment analysis was performed through hypergeometric overlap analysis of the Mycobrowser func-
tional categories (Kapopoulou et al., 2011) for each gene. Further enrichment analysis of the MLEPblue module virulence genes
was performed by the Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang et al., 2009). Human module
gene enrichment was performed using Gene Set Enrichment Analysis (GSEA) (Subramanian et al., 2005) of the Molecular Signatures
Database (MSigDB) (Liberzon et al., 2011). Further enrichment analysis of the HUMANgreenyellow module was performed by Inge-
nuity Pathways Analysis (QIAGEN, Hilden, Germany). Canonical pathway ‘Communication between Innate and Adaptive Immune
Cells’ was edited to include only the portion of the pathway which had enriched genes and for visual clarity by the Pathway Designer
function.
Pearson correlation plots (Figures 4D and 5A) were constructed using the ‘corrplot’ R package (R Core Team, 2013; Wei, 2017).
Correlation significance test for association between paired samples was performed by the R function ‘‘cor.test()’’ using Pearson’s
product moment correlation coefficient. Three-way partial correlations performed using the ‘‘ppcorr’’ R package (Kim, 2015). The
two-tailed Student’s t test was used when individual comparisons between two groups were performed. Individual details of statis-
tical analyses are explained in the figure legends.
DATA AND SOFTWARE AVAILABILITY
The accession number for the dual RNaseq data for leprosy lesions reported in this paper is GEO: GSE125943. Signature Visualiza-
tion Tool (SaVanT) can be accessed online at http://newpathways.mcdb.ucla.edu/savant.e3 Cell Reports 26, 3574–3585.e1–e3, March 26, 2019
